0000950170-24-022120.txt : 20240228
0000950170-24-022120.hdr.sgml : 20240228
20240228161842
ACCESSION NUMBER: 0000950170-24-022120
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240226
FILED AS OF DATE: 20240228
DATE AS OF CHANGE: 20240228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Walker John D. III
CENTRAL INDEX KEY: 0001843398
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33268
FILM NUMBER: 24695670
MAIL ADDRESS:
STREET 1: C/O CENTRAL GARDEN & PET COMPANY
STREET 2: 1340 TREAT BLVD STE 600
CITY: WALNUT CREEK
STATE: CA
ZIP: 94597
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CENTRAL GARDEN & PET CO
CENTRAL INDEX KEY: 0000887733
STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-MISCELLANEOUS NONDURABLE GOODS [5190]
ORGANIZATION NAME: 07 Trade & Services
IRS NUMBER: 680275553
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0928
BUSINESS ADDRESS:
STREET 1: 1340 TREAT BOULEVARD
STREET 2: SUITE 600
CITY: WALNUT CREEK
STATE: CA
ZIP: 94597
BUSINESS PHONE: 9259484000
MAIL ADDRESS:
STREET 1: 1340 TREAT BOULEVARD
STREET 2: SUITE 600
CITY: WALNUT CREEK
STATE: CA
ZIP: 94597
FORMER COMPANY:
FORMER CONFORMED NAME: CENTRAL GARDEN & PET COMPANY
DATE OF NAME CHANGE: 19941019
4
1
ownership.xml
4
X0508
4
2024-02-26
0000887733
CENTRAL GARDEN & PET CO
CENT
0001843398
Walker John D. III
1340 TREAT BLVD
SUITE 600
WALNUT CREEK
CA
94597-7578
false
true
false
false
President, Garden Consumer Pro
false
Class A Common Stock
2024-02-26
4
M
false
27856
21.76
A
105307
D
Class A Common Stock
2024-02-26
4
F
false
21562
36.86
D
83745
D
Class A Common Stock
2024-02-26
4
M
false
26316
22.80
A
110061
D
Class A Common Stock
2024-02-26
4
F
false
20780
36.86
D
89281
D
Units
10105
I
By 401(k) Plan
Stock Option (Right to Buy)
21.76
2024-02-26
4
M
false
27856
0
D
2025-02-13
Class A Common Stock
27856
0
D
Stock Option (Right to Buy)
22.80
2024-02-26
4
M
false
26316
0
D
2026-02-10
Class A Common Stock
26316
0
D
On December 7, 2023, Company declared a stock dividend, payable to all holders on record of Common Stock and Class A Common Stock as of January 8, 2024, of one share of Class A Common Stock for every four shares of Common Stock and Class A Common Stock outstanding. At the same time, pursuant to anti-dilution provisions , an option for 22,285 shares Class A Common Stock on January 8, 2024 became exercisable for 27,856 shares of Class A Common Stock.
Shares withheld by the Issuer in payment of the aggregate option exercise price and withholding tax liability incurred upon the above-reported exercise of options. The amount of shares withheld is based on the respective average of the high and low sales prices on the date of exercise.
On December 7, 2023, Company declared a stock dividend, payable to all holders on record of Common Stock and Class A Common Stock as of January 8, 2024, of one share of Class A Common Stock for every four shares of Common Stock and Class A Common Stock outstanding. At the same time, pursuant to anti-dilution provisions , an option for 21,053 shares Class A Common Stock on January 8, 2024 became exercisable for 26,316 shares of Class A Common Stock.
The units represent interests in the CENTA Stock Fund in the Issuer's 401(k) Plan, which consist of shares of CENTA stock and cash.
This option was previously reported as an option for 22,285 shares of Class A Common Stock at an exercise price of $27.20 per share, but was adjusted to reflect the stock dividend declared by Company on December 7, 2023. As a result of the stock dividend, the option also entitled the Reporting Person to receive, upon exercise, 5,571 shares of Class A Common Stock for no additional consideration.
Options were granted on February 13, 2019, and all shares are vested and have been exercised.
This option was previously reported as an option for 21,053 shares of Class A Common Stock at an exercise price of $28.50 per share, but was adjusted to reflect the stock dividend declared by Company on December 7, 2023. As a result of the stock dividend, the option also entitled the Reporting Person to receive, upon exercise, 5,263 shares of Class A Common Stock for no additional consideration.
Options were granted on February 10, 2020, and all shares are vested and have been exercised.
/s/Filomena Eickstaedt as Attorney-in-Fact for John D. Walker III
2024-02-28